Global Pegfilgrastim Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Pegfilgrastim Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

According to our (Global Info Research) latest study, the global Pegfilgrastim market size was valued at USD 56 million in 2023 and is forecast to a readjusted size of USD 76 million by 2030 with a CAGR of 4.6% during review period.

Pegfilgrastim is a PEGylated form of the recombinant human granulocyte colony-stimulating factor (GCSF) analog filgrastim. It serves to stimulate the production of white blood cells (neutrophils).

Pegfilgrastim, also known by the brand name Neulasta, is a medication used to stimulate the production of white blood cells in patients undergoing chemotherapy. The global market for pegfilgrastim is driven by several factors. One major driver for the global market is the increasing incidence and prevalence of cancer worldwide. As the number of cancer patients undergoing chemotherapy grows, the demand for medications like pegfilgrastim to manage chemotherapy-induced neutropenia (low white blood cell counts) increases. This has contributed to the market drive for pegfilgrastim. Additionally, the growing awareness and understanding of the impact of neutropenia on patient outcomes have led to the incorporation of supportive care strategies, including the use of pegfilgrastim, in cancer treatment protocols. Healthcare professionals are recognizing the importance of maintaining patients' immune systems during chemotherapy, leading to increased utilization of pegfilgrastim. Another factor driving the global market is the increasing adoption of biosimilar versions of pegfilgrastim. Biosimilars are biologic medications that are highly similar to a reference or originator biologic drug. The introduction of biosimilar pegfilgrastim options has created competition in the market, making the medication more accessible and affordable for patients and healthcare systems. Moreover, advancements in drug delivery systems have played a role in driving the market for pegfilgrastim. For instance, the development of on-body injectors that provide a longer duration of drug release has improved convenience and patient compliance. These innovations have contributed to the market drive for pegfilgrastim. Furthermore, government initiatives and policies aimed at reducing the healthcare burden of cancer treatment have also influenced the market drive for pegfilgrastim. Various healthcare systems and insurance providers have implemented measures to improve the affordability and accessibility of essential cancer treatments, including pegfilgrastim.

The Global Info Research report includes an overview of the development of the Pegfilgrastim industry chain, the market status of Hospital (Originator Biologic Drug, Biosimilar Versions), Drug store (Originator Biologic Drug, Biosimilar Versions), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Pegfilgrastim.

Regionally, the report analyzes the Pegfilgrastim markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Pegfilgrastim market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:

The report presents comprehensive understanding of the Pegfilgrastim market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Pegfilgrastim industry.

The report involves analyzing the market at a macro level:

Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Originator Biologic Drug, Biosimilar Versions).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Pegfilgrastim market.

Regional Analysis: The report involves examining the Pegfilgrastim market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Pegfilgrastim market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Pegfilgrastim:

Company Analysis: Report covers individual Pegfilgrastim manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Pegfilgrastim This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Drug store).

Technology Analysis: Report covers specific technologies relevant to Pegfilgrastim. It assesses the current state, advancements, and potential future developments in Pegfilgrastim areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Pegfilgrastim market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation

Pegfilgrastim market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
Originator Biologic Drug
Biosimilar Versions

Market segment by Application
Hospital
Drug store

Major players covered
Amgen
Mylan
Roche

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Pegfilgrastim product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Pegfilgrastim, with price, sales, revenue and global market share of Pegfilgrastim from 2019 to 2024.

Chapter 3, the Pegfilgrastim competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Pegfilgrastim breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Pegfilgrastim market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Pegfilgrastim.

Chapter 14 and 15, to describe Pegfilgrastim sales channel, distributors, customers, research findings and conclusion.